Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Breast Cancer and Ovarian Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT02012699
What this trial is testing

Integrated Cancer Repository for Cancer Research

Who this might be right for
Pancreatic CancerThyroid CancerLung Cancer+47 more
University of Nebraska 999,999
Post-approval studies (Phase 4)Study completedNCT02661932
What this trial is testing

Fertility Preservation in Breast Cancer Patients

Who this might be right for
Breast NeoplasmsFertility
Erasme University Hospital 65
Testing effectiveness (Phase 2)Looking for participantsNCT05941507
What this trial is testing

Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
LigaChem Biosciences, Inc. 300
Not applicableEnded earlyNCT00957736
What this trial is testing

Chronic Graft-Versus-Host Disease in Patients Who Have Undergone Donor Stem Cell Transplant

Who this might be right for
Cancer
Vanderbilt-Ingram Cancer Center 252
Not applicableLooking for participantsNCT07406087
What this trial is testing

Navigation Intervention for Adolescent and Young Adult Cancer Survivors

Who this might be right for
Breast CancerOvarian CancerCervical Cancer+6 more
Kaiser Permanente 25
Not applicableStudy completedNCT02785887
What this trial is testing

Impact of Geriatrician Interventions on Chemotherapy Delivery in Vulnerable Elderly Oncology Patients

Who this might be right for
Breast CancerLung CancerOvarian Cancer+3 more
Azienda USL 4 Prato 233
Not applicableStudy completedNCT00579007
What this trial is testing

Decision-making Regarding Prophylactic Mastectomy and Oophorectomy in Women Seeking Genetic Counseling and Testing for BRCA1/2 Mutations

Who this might be right for
Breast CancerOvarian Cancer
Memorial Sloan Kettering Cancer Center 224
Early research (Phase 1)Looking for participantsNCT04969835
What this trial is testing

A Study Evaluating the Safety, Pharmacokinetics and Early Efficacy of AVA6000 in Solid Tumours

Who this might be right for
Salivary Gland TumorUrothelial CarcinomaOvarian Carcinoma+2 more
Avacta Life Sciences Ltd 158
Early research (Phase 1)Ended earlyNCT04586335
What this trial is testing

Study of CYH33 in Combination With Olaparib an Oral PARP Inhibitor in Patients With Advanced Solid Tumors.

Who this might be right for
Ovarian CancerBreast CancerSolid Tumor+2 more
Haihe Biopharma Co., Ltd. 24
Not applicableUnknownNCT01470235
What this trial is testing

Hypodontia and Ovarian Cancer

Who this might be right for
Ovarian CancerHypodontiaBreast Cancer+1 more
University of Aarhus 200
Testing effectiveness (Phase 2)Active Not RecruitingNCT01116648
What this trial is testing

Cediranib Maleate and Olaparib in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Peritoneal Cancer or Recurrent Triple-Negative Breast Cancer

Who this might be right for
Fallopian Tube CarcinomaOvarian Endometrioid AdenocarcinomaOvarian High Grade Serous Adenocarcinoma+4 more
National Cancer Institute (NCI) 155
Early research (Phase 1)Study completedNCT07648940
What this trial is testing

Bioequivalence Study of Liposomal Doxorubicin 20 mg/10 mL (Doxopeg® vs Caelyx®) in Advanced Cancer Patients

Who this might be right for
Advanced Ovarian CancerMetastatic Breast Cancer
Zodiac Produtos Farmaceuticos S.A. 74
Early research (Phase 1)Ended earlyNCT02628535
What this trial is testing

Safety Study of MGD009 in B7-H3-expressing Tumors

Who this might be right for
MesotheliomaBladder CancerMelanoma+10 more
MacroGenics 67
Not applicableStudy completedNCT05939440
What this trial is testing

Interventions to Decrease Financial Toxicity

Who this might be right for
Cancer, BreastCancer ColorectalCancer, Ovarian+3 more
University of Alabama at Birmingham 60
Not applicableLooking for participantsNCT05349227
What this trial is testing

Comprehensive Outcomes for After Cancer Health

Who this might be right for
Ovarian CancerBreast CancerLung Cancer+8 more
Pack Health 625
Testing effectiveness (Phase 2)Looking for participantsNCT05902988
What this trial is testing

A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer

Who this might be right for
Advanced Solid TumorHigh Grade Serous Adenocarcinoma of OvarySquamous Non-small-cell Lung Cancer+7 more
Volastra Therapeutics, Inc. 200
Early research (Phase 1)Study completedNCT01772004
What this trial is testing

Avelumab in Metastatic or Locally Advanced Solid Tumors (JAVELIN Solid Tumor)

Who this might be right for
Solid Tumors
EMD Serono Research & Development Institute, Inc. 1,756
Not applicableStudy completedNCT02786147
What this trial is testing

Identification and Referral of Women at Risk for Hereditary Breast/Ovarian Cancer

Who this might be right for
Hereditary Breast and Ovarian Cancer
Emory University 665
Early research (Phase 1)Study completedNCT01588678
What this trial is testing

A Open-Label, Multiple Ascending Dose Study of DS-3078a, an Oral TORC1/2 Kinase Inhibitor, in Subjects With Advanced Solid Tumors or Lymphomas

Who this might be right for
Advanced Solid TumorLymphoma
Daiichi Sankyo 32
Testing effectiveness (Phase 2)Ended earlyNCT01383408
What this trial is testing

Distinction Between Lung Cancer and Gynecological Cancers by Canine Scent Detection

Who this might be right for
Lung CancerBreast CancerOvarian Cancer
Schillerhoehe Hospital 752
Next Page